Published in Circulation on February 01, 1981
Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis. Br Heart J (1988) 0.85
Haemodynamic and metabolic effects of dazoxiben at rest and during atrial pacing. Br J Clin Pharmacol (1983) 0.78
Study on the platelet factor and beta-thromboglobulin in the patients with ischemic heart disease. Korean J Intern Med (1986) 0.75
Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science (1985) 5.23
Deep-vein thrombosis. N Engl J Med (1994) 4.18
Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut (1983) 2.53
Nucleotide sequence of pre-pro-von Willebrand factor cDNA. Nucleic Acids Res (1986) 2.32
Further evidence for overlapping transcriptional units in an Escherichia coli cell envelope-cell division gene cluster: DNA sequence and transcriptional organization of the ddl ftsQ region. J Bacteriol (1986) 2.23
Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. Eur Respir J (2000) 2.15
Management of heparin therapy: Controlled prospective trial. N Engl J Med (1975) 2.07
Estimation of the cortical functional connectivity with the multimodal integration of high-resolution EEG and fMRI data by directed transfer function. Neuroimage (2005) 2.06
Structure of pre-pro-von Willebrand factor and its expression in heterologous cells. Nature (1987) 2.04
Living with Parkinson's disease. N Engl J Med (1996) 2.02
Purification and binding properties of human platelet factor four. J Biol Chem (1976) 1.94
Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II. Science (1986) 1.91
Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry (1991) 1.88
Prevention of venous thromboembolism. Chest (1992) 1.81
Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement. J Bone Joint Surg Am (1974) 1.78
Calpain-catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatase 1B (PTP-1B) in human platelets. EMBO J (1993) 1.75
Fatal myocardial infarction in marathon racing. Ann Intern Med (1976) 1.71
Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med (1977) 1.65
Measuring and managing quality of surgery. Statistical vs incidental approaches. Arch Surg (1992) 1.64
Pseudoaneurysm of the inferior gluteal artery. Can Assoc Radiol J (1992) 1.63
Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin. J Am Coll Cardiol (1994) 1.60
Assessment of axillary lymph node status. Ann Surg (1980) 1.59
Characterization of a new megakaryocytic cell line: the Dami cell. Blood (1988) 1.58
Prevention of venous thromboembolism in orthopaedic patients. J Bone Joint Surg Am (1976) 1.56
Characterization of "ecto-ATPase" of human blood platelets. Arch Biochem Biophys (1967) 1.55
Composition of the von Willebrand factor storage organelle (Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells. J Cell Biol (1987) 1.53
Measurement of ionized calcium in blood platelets with the photoprotein aequorin. Comparison with Quin 2. J Biol Chem (1985) 1.49
Platelets and coronary artery disease. N Engl J Med (1996) 1.47
Randomized trial of albumin vs. electrolyte solutions during abdominal aortic operations. Surgery (1975) 1.45
The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers. Cell (1988) 1.44
Association between HIV distal symmetric polyneuropathy and Mycobacterium avium complex infection. J Neurol Neurosurg Psychiatry (1996) 1.44
Surgical experience of deeply jaundiced patients with bile duct obstruction. Br J Surg (1984) 1.43
Mapping the glycoprotein Ib-binding site in the von willebrand factor A1 domain. J Biol Chem (2000) 1.43
Cyclic AMP and platelet function. N Engl J Med (1972) 1.42
Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest (1980) 1.42
von Willebrand factor binding to platelet GpIb initiates signals for platelet activation. J Clin Invest (1991) 1.41
DAMI cell line. Blood (1997) 1.41
Cyclic 3',5'-adenosine monophosphate in human blood platelets. Nature (1969) 1.40
Experience with pediatric lung transplantation. J Pediatr (1994) 1.39
Two TaqI polymorphisms in the 5' region of the von Willebrand factor (vWF) gene. Nucleic Acids Res (1989) 1.38
Identification of platelet receptors for prostaglandin I2 and D2. J Biol Chem (1979) 1.36
Inhibition of platelet function by organic nitrate vasodilators. Blood (1980) 1.35
Young students' use of the Internet for mental health information and support. J Psychiatr Ment Health Nurs (2010) 1.30
Giant cell tumor of the distal radius. J Hand Surg Am (1995) 1.29
Expression of mucin synthesis and secretion in human tracheobronchial epithelial cells grown in culture. Am J Respir Cell Mol Biol (1990) 1.28
Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function. J Clin Invest (1971) 1.26
Mapping and characterization of mutants of the Escherichia coli cell division gene, ftsA. Mol Microbiol (1988) 1.25
Radical surgery in locally advanced cancer of the large bowel. Clin Oncol (1975) 1.24
Native conformation of human von Willebrand protein. Analysis by electron microscopy and quasi-elastic light scattering. J Biol Chem (1985) 1.24
Prophylaxis of venous thromboembolism: analysis of cost effectiveness. Ann Surg (1980) 1.23
Interaction of the von Willebrand factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant vWF a domain polypeptides. J Biol Chem (1995) 1.21
Acute aortic thrombosis in antithrombin III deficiency. JAMA (1981) 1.20
Biochemical mechanisms of tumor invasion and metastases. Prog Clin Biol Res (1988) 1.20
Does the conformation of adsorbed fibrinogen dictate platelet interactions with artificial surfaces? Blood (1986) 1.19
Venous thrombosis made easy. N Engl J Med (1986) 1.19
The results of treatment of supracondylar fracture above total knee arthroplasty. J Arthroplasty (1990) 1.19
Distribution of fibrinogen, and platelet factors 4 and XIII in subcellular fractions of human platelets. Br J Haematol (1975) 1.18
Vascular permeation of platelet factor 4 after endothelial injury. Science (1980) 1.17
Platelet membrane glycoprotein IIIa contains target antigens that bind anti-platelet antibodies in immune thrombocytopenias. J Clin Invest (1984) 1.17
Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling. J Thromb Haemost (2011) 1.17
The interaction of the von Willebrand factor-A1 domain with platelet glycoprotein Ib/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein. J Biol Chem (1993) 1.17
Cyclic 3',5'-adenosine monophosphate in human blood platelets. IV. Regulatory role of cyclic amp in platelet function. Ann N Y Acad Sci (1972) 1.17
The interaction of platelet factor four and glycosaminoglycans. Arch Biochem Biophys (1985) 1.16
Platelet adhesion to cultured vascular endothelial cells. A quantitative monolayer adhesion assay. J Lab Clin Med (1982) 1.16
The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts. J Thorac Cardiovasc Surg (1982) 1.16
Prevention of deep vein thrombosis in urological patients: a controlled, randomized trial of low-dose heparin and external pneumatic compression boots. Surgery (1978) 1.15
Involutional melancholia revisited. Am J Psychiatry (1984) 1.14
Prostaglandin receptors on human platelets. Structure-activity relationships of stimulatory prostaglandins. Biochem J (1978) 1.14
Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. Measurement with 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin. J Clin Invest (1986) 1.12
Orthotopic liver transplantation in patients with cystic fibrosis. Pediatrics (1987) 1.12
Elevation of platelet factor four in acute myocardial infarction: measurement by radioimmunoassay. J Lab Clin Med (1978) 1.11
Role of cyclic AMP in platelet function. Adv Cyclic Nucleotide Res (1972) 1.11
Effect of perioperative low-dose heparin administration on the course of colon cancer. Surgery (1983) 1.10
Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition. J Clin Invest (1978) 1.10
Nonbronchoscopic bronchoalveolar lavage in mechanically ventilated infants: technique, efficacy, and applications. Pediatr Pulmonol (1993) 1.10
Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports. Schizophr Bull (1990) 1.10
Design and synthesis of a helix heparin-binding peptide. Biochemistry (1992) 1.10
Incorporation of labelled nucleotides and aggregation of human blood platelets. Thromb Diath Haemorrh (1966) 1.09
Blood rheology: effect of fibrinogen deduced by addition. Circ Res (1966) 1.09
Reduction in venous thromboembolism by agents affecting platelet function. N Engl J Med (1971) 1.09
The results of revision total knee arthroplasty. Clin Orthop Relat Res (1988) 1.08
Cost effectiveness of prophylaxis of venous thromboembolism. J R Soc Med (1981) 1.08
Cerebral arterial spasm. Modification by inhibition of platelet function. Arch Neurol (1973) 1.06
Viscometry of human blood for shear rates of 0-100,000 sec-1. Nature (1965) 1.05
pp60src is an endogenous substrate for calpain in human blood platelets. J Biol Chem (1993) 1.05
Objective tinnitus in patients with atherosclerotic carotid artery disease. Am J Otol (1994) 1.05
Diagnostic tests and prognostic indicators in acute pancreatitis. J R Coll Surg Edinb (1982) 1.04
Upper gastrointestinal bleeding. A significant complication after surgery for relief of obstructive jaundice. Ann Surg (1984) 1.04
Enhancement of platelet function by superoxide anion. J Clin Invest (1977) 1.04
Cyclic GMP response in vivo to cholinergic stimulation of gastric mucosa. Nature (1974) 1.03
Laparoscopic versus open appendectomy: a prospective randomized trial of 81 patients. Can J Surg (1996) 1.03
Is prostacyclin a physiologically important circulating anti-platelet agent? Nature (1980) 1.03
Nonpenetrating vascular injury to the subclavian artery. J Vasc Surg (1988) 1.02
Isolation and characterization of the human fibrillar collagen genes. Ann N Y Acad Sci (1985) 1.02
Molecular and cellular biology of von Willebrand factor. Prog Hemost Thromb (1989) 1.02
Influence of plasma osmolarity on the rheology of human blood. J Appl Physiol (1967) 1.01
Pseudomonas cepacia empyema necessitatis after lung transplantation in two patients with cystic fibrosis. Chest (1994) 1.01